Physician profile
Casey Lewis
NPI 1538201892
$2,087.15
in general payments reported to CMS, 2019-2025
17 companies · $351 in 2025
The $351 reported for 2025 was more than what 88% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.07 · 2020: $195 · 2021: $380 · 2022: $364 · 2023: $333 · 2024: $371 · 2025: $351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,055.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,055.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $352.31 | 2022-2025 | Azstarys |
| Pfizer INC. | $343.52 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $297.19 | 2019-2025 | Vaxneuvance, Gardasil 9, M-M-R II |
| Tris Pharma INC | $160.65 | 2020-2023 | Dyanavel Xr |
| Glaxosmithkline, LLC. | $157.60 | 2019-2025 | Pediarix, Rotarix, Bexsero |
| Neos Therapeutics, LP | $137.57 | 2020-2025 | Cotempla Xr-Odt |
| Ironshore Pharmaceuticals INC. | $106.38 | 2019-2024 | Jornay Pm |
| Sanofi Pasteur INC. | $104.74 | 2020-2023 | |
| Supernus Pharmaceuticals, INC. | $98.92 | 2021-2025 | Qelbree, Qelbree |
| Integra Lifesciences Corporation | $92.67 | 2021 | |
| Cranial Technologies, INC | $50.18 | 2024 | Doc Band |
| Collegium Pharmaceutical, INC. | $47.44 | 2025 | Jornay Pm |
| Sobi, INC | $43.72 | 2020-2022 | |
| Kowa Pharmaceuticals America, INC. | $37.51 | 2025 | Zoryve |
| Kaleo, INC. | $28.69 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $14.05 | 2024 | Wegovy |
| Adlon Therapeutics L.P. | $14.01 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Casey Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.